Skip to content

Author

M. Verneris

We have 3 of 26 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Child Opportunity Index and Survival After Pediatric Hematopoietic Cell Transplantation for Acute Leukemia

In this single-institution cohort, children from very low opportunity neighborhoods experienced inferior survival after HCT for acute leukemia in exploratory analyses, and neighborhood opportunity should be investigated in larger, multi-institutional cohorts as a clinical risk factor for poor outcomes.

Katherine T. Lind, Cheng-Chang Wu, A. Nicklawsky et al. · 0 citations
Open access Aug 2026

Progressive deterioration of adaptive immune repertoires in Down syndrome linked to interferon hyperactivity and lymphoid tissue disorganization

Persons with Down syndrome (DS), the genetic condition caused by trisomy 21 (T21), display strong dysregulation of adaptive immunity, which underlies high risk of complications from infections, widespread autoimmunity, and poor vaccine responses. However, the mechanisms by which T21 dysregulates adaptive immunity acros...

Micah G. Donovan, N. Eduthan, Brian F. Niemeyer et al. · 0 citations
Open access Jul 2026

Engineered TCR therapy targeting lipid antigens in AML 2306228

CD1d-specific killing was shown that was dependent on CD1d expression, and in cases of high CD1d expression, may be dependent on endogenously self-lipids found in AML cells.

Amandip Bangar, B. Linden, Andrew Kent et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.